GlobeNewswire by notified

Arcadis Trading Update Q1 2022

Share

Continued strong organic revenue and record backlog

  • Strong order intake inclusive of projects in energy transition, environmental restoration and new mobility, underpinning the strategy
  • Continued client demand for sustainable solutions and advisory, resulting in net revenue of €688 million and organic net revenue growth of 5.6%1)
  • Record backlog at €2.3 billion. Organic year-on-year backlog growth of 7.6%1)
  • Operating EBITA margin improved to 9.4% (Q1’21: 9.2%)
  • Net Working Capital of 12.9% (Q1’21: 15.3%) and DSO of 70 days (Q1’21: 78 days)

Amsterdam, 4 May 2022 – Arcadis (EURONEXT: ARCAD), the leading global Design & Consultancy organization for natural and built assets,sees a continued growing client demand across its Global Business Areas (GBAs), resulting in an organic net revenuegrowth of 5.6%,and an organic backlog growth of 7.6%. Operating EBITA margin increased to 9.4% (last year: 9.2%),driven by improved performance across allGBAs.

Peter Oosterveer, CEO Arcadis said: “The impact of the crisis in Ukraine is undoubtedly being felt all around the world. We are shocked and appalled by the senseless violence and suffering, and while Arcadis does not have any employees, offices, or live projects in either Ukraine, Russia or Belarus, we are supporting humanitarian efforts through donations and volunteering initiatives. With the war now into its third month, we call on all parties to do their utmost to bring the crisis to a peaceful end.

During the quarter we have seen a further increase of clients looking for alternative energy solutions as they accelerate the transition to net zero carbon emissions and prioritize secure and renewable sources, which has been an important contributor to the organic backlog growth of 7.6%, to a record level of €2.3 billion. The organic revenue growth also improved to 5.6% this quarter.

Notwithstanding the geopolitical instability, the increase in energy costs and high inflation in a number of regions, as well as renewed COVID-19 lockdowns in China, our order intake and record backlog this quarter positions us well for the remainder of the year.

Going forward, our focus will include a further increase of our efforts and investments to provide an attractive workplace for the most talented people in our industry. Our strong purpose of improving quality of life, combined with our global reach and our capabilities for delivering sustainable solutions to our clients creates a solid foundation for further growth.” 
1)underlying growth excluding the impact of currency movements,acquisitions or footprint reductions, such as the Middle East, winddowns or divestments

KEY FIGURES

in € millions First quarter
Period ended 31 March 202220222021change
Gross revenues8798128%
Net revenues6886329%
Organic growth1)5.6%
EBITDA87844%
EBITDA margin12.6%13.2%
EBITA655715%
EBITA margin9.5%9.0%
Operating EBITA2)645811%
Operating EBITA margin9.4%9.2%
Free Cash Flow3) -51-39-31%
Net Working Capital %12.9%15.3%
Days Sales Outstanding7078
Net Debt205376-45%
Backlog net revenues (billions)         2.3          2.1 11%
Backlog organic growth (y-o-y)1)7.6%

1)underlying growth excluding the impact of currency movements,acquisitions or footprint reductions, such as the Middle East, winddowns or divestments
2)excluding restructuring, acquisition & divestment costs
3) Free Cash flow: Cash Flow from Operations – Capex – Lease liabilities

INCOME STATEMENT & BACKLOG
Net revenues totaled €688 million and increased organically 5.6%. Growth was driven by all three GBAs, with Mobility being particularly strong in US and UK. The currency impact was 5%. The operating EBITA margin improved to 9.4% (Q1 2021: 9.2%), driven by all three GBAs.

At the end of March 2022 backlog was at a record high of €2.3 billion (Q1 2021: €2.1 billion). Organic backlog increased by 7.6% year-over-year, with a positive contribution of all three GBAs. Book to Bill was 1.141) in the quarter, driven by order intake from Key Clients.
1)Excluding footprint reductions, such as the Middle East, winddowns or divestments

BALANCE SHEET & CASH FLOW
Net working capital as a percentage of annualized gross revenues improved to 12.9% (Q1 2021: 15.3%) and Days Sales Outstanding (DSO) decreased to 70 days (Q1 2021: 78 days), resulting from our disciplined working capital management. The balance sheet strengthened year-on-year, resulting in a significantly lower net debt of €205 million (Q1 2021: €376 million).
Good free cash flow performance of €-51 million during the first quarter (Q1 2021: €-39 million), considering the one-off effect in Q1 2021 of a very low accounts payable position as of Dec 31st, 2020.

REVENUES BY GLOBAL BUSINESS AREA
As of January 1st, 2022 Arcadis transitioned to a its new global structure and now operates through three Global Business Areas (GBAs): Resilience, Places and Mobility. This will enable clients to benefit from Arcadis’ global resources, expertise and capabilities.

RESILIENCE
The Resilience GBA focuses on services and solutions to protect, adapt and improve our natural environment and water resources, while sustainably powering our world for future generations.
During the first quarter, Arcadis’ clients have accelerated their investments in energy transition, notably in the UK and the Netherlands, and we experienced increased demand for consultancy services as well as remediation and restoration services for oil and gas clients. Arcadis’ US leadership position in PFAS remediation was scaled to Belgium, where the government has tightened the PFAS emission standards.

(41% of net revenues)
in € millions First quarter
Period ended 31 March 202220222021change
Net revenues28125112%
Organic growth1)6.9%

PLACES
The Places GBA is focused on creating smart and sustainable places for owners, investors, users and communities across the real estate sector. The construction and operation of buildings generates up to 40% of annual global greenhouse gas emissions and one of Arcadis’ priorities is to help clients reduce carbon over the full lifecycle of their assets.
Growth in the first quarter was driven by UK and Australia, while China was impacted by COVID-19 lockdowns and CallisonRTKL declined year-on-year from turnaround measures. Strong order intake from clients developing intelligent buildings, including the development of Datacenters and Giga-factories for electric vehicle battery production.

(33% of net revenues)
in € millions First quarter
Period ended 31 March 202220222021change
Net revenues2282194%
Organic growth1)1.1%

MOBILITY
With better transport links crucial to creating thriving and connected cities and communities, the Mobility GBA collaborates with transport owners, operators and contractors to deliver design, asset and program management for mobility solutions across the world. Drawing on Arcadis’ experience in rail, and electric vehicle adoption, we have seen strong revenue growth across the board and particularly in the US, UK and Australia.

(26% of net revenues)
in € millions First quarter
Period ended 31 March 202220222021change
Net revenues17916211%
Organic growth1)9.4%

1)underlying growth excluding the impact of currency movements,acquisitions or footprint reductions, such as the Middle East, winddowns or divestments

FINANCIAL CALENDAR

  • 12 May 2022 – Annual General Meeting of Shareholders 2021
  • 28 July 2022 – Q2 and half year 2022 Results
  • 27 October 2022 – Q3 2022 Trading update

For further information please contact:
Arcadis Investor Relations
Christine Disch
Mobile: +31 (0)6 1537 6020
E-mail: christine.disch@arcadis.com

Arcadis Corporate Communications
Chris Wiggan
Mobile: +44 (0)7966 404889
E-mail: chris.wiggan@arcadis.com

Analyst meeting
Arcadis will hold an analyst webcast to discuss the Q1 results for 2022. The analyst meeting will be held at 10.00 hours CET today. The webcast can be accessed via the investor relations section on the company’s website at https://www.arcadis.com/en/investors/investor-calendar/2022/trading-update-q1-2022

About Arcadis
Arcadis is a leading global Design & Consultancy organization for natural and built assets. Applying our deep market sector insights and collective design, consultancy, engineering, project and management services we work in partnership with our clients to deliver exceptional and sustainable outcomes throughout the lifecycle of their natural and built assets. We are 29,000 people, active in over 70 countries that generate €3.4 billion in revenues. We support UN-Habitat with knowledge and expertise to improve the quality of life in rapidly growing cities around the world. www.arcadis.com.

REGULATED INFORMATION
This press release contains information that qualifies or may qualify as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

FORWARD LOOKING STATEMENTS
Statements included in this press release that are not historical facts (including any statements concerning investment objectives, other plans and objectives of management for future operations or economic performance, or assumptions or forecasts related thereto) are forward-looking statements. These statements are only predictions and are not guarantees. Actual events or the results of our operations could differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements are typically identified by the use of terms such as “may”, “will”, “should”, “expect”, “could”, “intend”, “plan”, “anticipate”, “estimate”, “believe”, “continue”, “predict”, “potential” or the negative of such terms and other comparable terminology. The forward-looking statements are based upon our current expectations, plans, estimates, assumptions and beliefs that involve numerous risks and uncertainties. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control. Although we believe that the expectations reflected in such forward-looking statements are based on reasonable assumptions, our actual results and performance could differ materially from those set forth in the forward-looking statements.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Nextensa NV/SA : Shares repurchase26.5.2022 17:40:00 CEST | Press release

PRESS RELEASE REGULATED INFORMATION Brussels, 26 May 2022 – 5.40 PM CEST Nextensa NV/SA : Shares repurchase In accordance with article 8:4 of the Royal Decree of 29 April 2019 in execution of the Belgian Code of Companies and Associations, Nextensa announces that in the period between May 19, 2022 and May 25, 2022 included it has repurchased 1,889 treasury shares on Euronext Brussels as part of its announced share buy-back program1. The shares were repurchased at an average price (rounded) of € 68.00 per share. This share repurchase transaction was carried out to cover the purchase plans for the benefit of the executive management of Nextensa, and this within the limits set down in the (renewed) share repurchase authorization as granted by the extraordinary general meeting of shareholders on 19 July 2021. Detailed operations per day DateNumber of sharesAverage price (€)Minimum price (€)Maximum price (€)Total price (€)19/05/202245067.8667.7067.9030,535.0020/05/202245068.4868.4068.9030,8

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons26.5.2022 15:00:33 CEST | Press release

26 May 2022 VOLTA FINANCE LIMITED (VTA / VTAS) Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons On 24 May 2022, Mr Paul Meader, Director and Chairman of the Board of the Company, transferred 3,130 shares in the Company to his wife, Sarah Kingwell. Following this transaction the total interests in the Company of Mr Meader (and his Closely Associated Persons) remain unchanged at 48,175 shares, representing 0.13% of the issued shares in the Company. The below notification, made in accordance with the requirements of article 19.3 of the EU Market Abuse Regulation, gives further details: 1 Details of the person discharging managerial responsibilities / person closely associated a) Name 1) Paul Meader 2) Sarah Kingwell 2 Reason for the notification a) Position/status 1) Director and Chairman 2) PCA b) Initial notification /Amendment Initial Notification 3 Details of the issuer, emission allowance market participant, auction platfor

Mandalay Resources Corporation tillkännager resultatet av årsstämman26.5.2022 14:41:34 CEST | Pressemelding

TORONTO, May 26, 2022 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation (”Mandalay” eller ”bolaget”) (TSX: MND, OTCQB: MNDJF) har nöjet att tillkännage resultaten från årsstämman (”mötet”) som hölls virtuellt idag. Alla resolutioner som presenterades vid mötet godkändes av aktieägarna och röstningen som skedde genom fullmakt motsvarade 67,63 % av de totalt utestående aktierna på avstämningsdagen. Val av styrelseledamöter Antalet styrelseledamöter var oförändrat med sju ledamöter och var och en av de sju nominerade som fanns listade i bolagsledningens informationsutskick från den 14 april 2022 återvaldes till bolagsstyrelsen. Abraham Jonker fortsätter som oberoende samordnande ledamot och Bradford Mills fortsätter som ordförande. Resultaten av rösterna genom ombud anges nedan. ResolutionVotes Cast by Proxy For% ForVotes Cast by Proxy Withheld% WithheldBradford A. Mills61,552,12099.95329,1930.047Abraham Jonker61,551,31399.95130,0000.049Amy Freedman61,547,53899.94533,7750.055Dominic Duff

Interim results for the period ended March 31, 202226.5.2022 13:30:47 CEST | Press release

Golar LNG Limited ("Golar" or "the Company") reports Q1 2022 ("Q1") Net income of $345.2 million.Adjusted EBITDA1 of $93.4 million for the quarter inclusive of FLNG Hilli, Golar Arctic and Golar Tundra but excluding the 8 TFDE vessels and management companies sold to Cool Company Ltd. ("CoolCo"). Sold 6.2 million New Fortress Energy Inc. ("NFE") shares in Q2 2022 ("Q2") realizing net cash proceeds of $253 million. Golar now owns 12.4 millionNFE shares following the sale.Q1 Total Golar Cash and Listed Securities1 position increased by $0.4 billion to $1.3 billion. Golar's share of Contractual Debt1 decreased by $0.5 billion to $1.7 billion in Q1 and a further $0.5 billion in Q2 after sale of remaining carriers to CoolCo in April.Agreed to sell the steam turbine carrier Golar Arctic as a converted FSRU to Italy's Snam for 269 million Euros ($288 million). Strong progress made on opportunities for FSRU Golar Tundra and on pipeline of FLNG projects. Shipping spin-off: A key focus for Q1 wa

Dante Labs highlights advancements to its drug discovery development program, demonstrating the value of genomic data to drug discovery26.5.2022 13:30:00 CEST | Press release

– Company announces rebranding to Dante Genomics to reflect its broader global efforts – NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, highlights significant progress made in its drug discovery development program with six drug candidates currently in the Company’s pipeline, applying Dante’s internal siRNA and mRNA technology to rare and common diseases. Since the company’s foundation, Dante has invested in a robust R&D program with the goal to create end-to-end solutions from diagnosis to therapy. Dante’s program began with a focus on rare disease, in response to a diagnosis of a patient with a rare disease for which there were no treatment therapies. Dante’s pipeline has evolved across multiple disease areas with four drug programs in full internal development and two in co-development to achieve validation and partner externally on clinical trials and commercialization. “Personalized medicine needs personalized data, a